WallStreetZenWallStreetZen

NASDAQ: CRBP
Corbus Pharmaceuticals Holdings Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

CRBP past revenue growth

How has CRBP's revenue growth performed historically?
Company
N/A
Industry
148.4%
Market
16.96%
CRBP's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
CRBP's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance

CRBP earnings and revenue history

Current Revenue
$0.0
Current Earnings
-$44.6M
Current Profit Margin
0%

CRBP Return on Equity

Current Company
-920.3%
Current Industry
-63.5%
Current Market
188%
CRBP's Return on Equity (-920.3%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when CRBP announces earnings.

CRBP Return on Assets

Current Company
-111.6%
Current Industry
2.9%
CRBP is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

CRBP Return on Capital Employed

Current Company
1,150.83%
Current Industry
19.5%
CRBP has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

CRBP vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
CRBP$0.00-$41.04M-$44.60M-100.00%N/A
FBLG$0.00-$15.90M-$19.06MN/AN/A
ADPT$170.28M-$182.30M-$225.25M+25.06%N/A
CBUS$1.82M-$244.57M-$267.63M+50.41%N/A
ITOS$12.60M-$108.13M-$112.64M-80.89%N/A
View Top Biotech Stocks

CRBP earnings dates

Next earnings date
May 7, 2024

Corbus Pharmaceuticals Holdings Earnings & Revenue FAQ

What were CRBP's earnings last quarter?

On Invalid Date, Corbus Pharmaceuticals Holdings (NASDAQ: CRBP) reported Q4 2023 earnings per share (EPS) of -$1.79, up 31.15% year over year. Total Corbus Pharmaceuticals Holdings earnings for the quarter were -$8.02 million. In the same quarter last year, Corbus Pharmaceuticals Holdings's earnings per share (EPS) was -$2.60.

If you're new to stock investing, here's how to buy Corbus Pharmaceuticals Holdings stock.

What was CRBP's earnings growth in the past year?

As of Q2 2024, Corbus Pharmaceuticals Holdings's earnings has grown year over year. Corbus Pharmaceuticals Holdings's earnings in the past year totalled -$44.60 million.

What is CRBP's earnings date?

Corbus Pharmaceuticals Holdings's earnings date is Invalid Date. Add CRBP to your watchlist to be reminded of CRBP's next earnings announcement.

What was CRBP's revenue last quarter?

On Invalid Date, Corbus Pharmaceuticals Holdings (NASDAQ: CRBP) reported Q4 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, Corbus Pharmaceuticals Holdings's revenue was $0.00.

What was CRBP's revenue growth in the past year?

As of Q2 2024, Corbus Pharmaceuticals Holdings's revenue has grown null year over year. Corbus Pharmaceuticals Holdings's revenue in the past year totalled $0.00.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.